Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 07 2023
Historique:
received: 27 01 2023
accepted: 22 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

Hepatitis C virus (HCV) is a major global health burden as the leading causative agent of chronic liver disease and hepatocellular carcinoma. While the main antigenic target for HCV-neutralizing antibodies is the membrane-associated E1E2 surface glycoprotein, the development of effective vaccines has been hindered by complications in the biochemical preparation of soluble E1E2 ectodomains. Here, we present a cryo-EM structure of an engineered, secreted E1E2 ectodomain of genotype 1b in complex with neutralizing antibodies AR4A, HEPC74, and IGH520. Structural characterization of the E1 subunit and C-terminal regions of E2 reveal an overall architecture of E1E2 that concurs with that observed for non-engineered full-length E1E2. Analysis of the AR4A epitope within a region of E2 that bridges between the E2 core and E1 defines the structural basis for its broad neutralization. Our study presents the structure of an E1E2 complex liberated from membrane via a designed scaffold, one that maintains all essential structural features of native E1E2. The study advances the understanding of the E1E2 heterodimer structure, crucial for the rational design of secreted E1E2 antigens in vaccine development.

Identifiants

pubmed: 37407593
doi: 10.1038/s41467-023-39659-z
pii: 10.1038/s41467-023-39659-z
pmc: PMC10322937
doi:

Substances chimiques

Antibodies, Neutralizing 0
Epitopes 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3980

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI168048
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI168251
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI158193
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132213
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI154100
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

J Hepatol. 2020 Apr;72(4):670-679
pubmed: 31785346
J Gen Virol. 2007 Apr;88(Pt 4):1144-1148
pubmed: 17374757
J Virol. 2014 Sep;88(18):10459-71
pubmed: 24965471
Vaccines (Basel). 2020 Feb 17;8(1):
pubmed: 32079254
Cold Spring Harb Perspect Med. 2021 Mar 1;11(3):
pubmed: 32341067
J Virol. 2019 Jun 28;93(14):
pubmed: 31068427
Front Immunol. 2018 Jun 11;9:1315
pubmed: 29951061
Immunity. 2022 Feb 8;55(2):341-354.e7
pubmed: 34990590
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Front Immunol. 2018 Apr 27;9:910
pubmed: 29755477
Expert Rev Vaccines. 2016 Dec;15(12):1535-1544
pubmed: 27267297
Vaccine. 2010 Aug 31;28(38):6367-73
pubmed: 20619382
Nat Struct Mol Biol. 2015 Nov;22(11):833-4
pubmed: 26581513
J Virol. 2016 Dec 16;91(1):
pubmed: 27795422
Sci Adv. 2019 Jan 02;5(1):eaav1882
pubmed: 30613781
Viruses. 2021 May 04;13(5):
pubmed: 34064532
J Biol Chem. 2015 Apr 17;290(16):10117-25
pubmed: 25737449
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6205-10
pubmed: 22492964
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2112008119
pubmed: 35263223
Science. 2022 Oct 21;378(6617):263-269
pubmed: 36264808
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12768-12773
pubmed: 27791120
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
JCI Insight. 2017 May 4;2(9):
pubmed: 28469084
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
PLoS Pathog. 2017 Dec 18;13(12):e1006735
pubmed: 29253863
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Virology. 2014 Jan 5;448:229-37
pubmed: 24314653
J Biol Chem. 2011 Sep 16;286(37):31984-92
pubmed: 21768113
Curr Opin Virol. 2016 Oct;20:55-63
pubmed: 27657659
Cell Rep. 2022 May 24;39(8):110859
pubmed: 35613596
PLoS One. 2013;8(3):e59776
pubmed: 23527266
Nat Commun. 2014 Sep 16;5:4874
pubmed: 25224686
J Virol. 2008 Jan;82(2):966-73
pubmed: 17977972
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Front Microbiol. 2018 Jan 15;8:2692
pubmed: 29379486
J Virol. 2023 Jan 31;97(1):e0178822
pubmed: 36519897
ACS Synth Biol. 2012 Apr 20;1(4):118-29
pubmed: 22558529
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Front Immunol. 2018 Sep 27;9:2146
pubmed: 30319614
Nat Med. 2008 Jan;14(1):25-7
pubmed: 18064037
Front Chem. 2021 Aug 23;9:689006
pubmed: 34497798
Gastroenterology. 2022 Feb;162(2):562-574
pubmed: 34655573
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Virus Res. 2018 Mar 15;248:53-62
pubmed: 29477639
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7569-7574
pubmed: 29954862
Biochim Biophys Acta. 2014 Mar;1838(3):784-92
pubmed: 24192053
J Virol. 2015 Oct;89(20):10333-46
pubmed: 26246575
Hepatology. 2014 Nov;60(5):1551-62
pubmed: 25043937
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Science. 2013 May 31;340(6136):1113-7
pubmed: 23618766
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Gastroenterology. 2020 Mar;158(4):1058-1071.e6
pubmed: 31809725
Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3
pubmed: 30439340
Gastroenterology. 2019 Jan;156(2):418-430
pubmed: 30268785
Nature. 2014 May 15;509(7500):381-4
pubmed: 24553139
J Virol. 1997 Jan;71(1):697-704
pubmed: 8985401
Science. 2013 Nov 29;342(6162):1090-4
pubmed: 24288331
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):
pubmed: 31548228
J Clin Invest. 2019 Aug 13;129(11):4786-4796
pubmed: 31408439
Front Immunol. 2014 Nov 10;5:550
pubmed: 25426115
J Mol Biol. 2015 Aug 14;427(16):2617-28
pubmed: 26135247
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):
pubmed: 33431677
J Biomed Sci. 2009 Sep 24;16:89
pubmed: 19778418
J Virol. 2010 Nov;84(22):11905-15
pubmed: 20844034
Cold Spring Harb Perspect Med. 2020 Jan 2;10(1):
pubmed: 31501263
Virus Res. 2016 Jun 2;217:63-70
pubmed: 26945847
PLoS Pathog. 2019 May 22;15(5):e1007759
pubmed: 31116791
Virology. 2003 Mar 15;307(2):255-65
pubmed: 12667795
Front Immunol. 2018 May 31;9:1194
pubmed: 29904384
J Virol. 2010 Oct;84(19):10159-68
pubmed: 20668082
Antiviral Res. 2010 Oct;88(1):80-5
pubmed: 20691736
J Virol. 2013 Feb;87(3):1605-17
pubmed: 23175356
Bioinformatics. 2005 Feb 1;21(3):379-84
pubmed: 15377502

Auteurs

Matthew C Metcalf (MC)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Benjamin M Janus (BM)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Rui Yin (R)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Ruixue Wang (R)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Johnathan D Guest (JD)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Edwin Pozharski (E)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.
Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.

Mansun Law (M)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Roy A Mariuzza (RA)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Eric A Toth (EA)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Brian G Pierce (BG)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Thomas R Fuerst (TR)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.

Gilad Ofek (G)

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA. gofek@umd.edu.
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA. gofek@umd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH